|
1.Navarro-Sanchez, E., P. Despres, and L. Cedillo-Barron, Innate immune responses to dengue virus. Arch Med Res, 2005. 36(5): p. 425-35. 2.Li, L.L., et al., Positive transcription elongation factor b (P-TEFb) contributes to dengue virus-stimulated induction of interleukin-8 (IL-8). Cell Microbiol. 12(11): p. 1589-603. 3.Conceicao, T.M., et al., Gene expression analysis during dengue virus infection in HepG2 cells reveals virus control of innate immune response. J Infect. 60(1): p. 65-75. 4.Rothman, A.L. and F.A. Ennis, Immunopathogenesis of Dengue hemorrhagic fever. Virology, 1999. 257(1): p. 1-6. 5.Clyde, K., J.L. Kyle, and E. Harris, Recent advances in deciphering viral and host determinants of dengue virus replication and pathogenesis. J Virol, 2006. 80(23): p. 11418-31. 6.Srikiatkhachorn, A., Plasma leakage in dengue haemorrhagic fever. Thromb Haemost, 2009. 102(6): p. 1042-9. 7.Spain-Santana, T.A., et al., MIP-1 alpha and MIP-1 beta induction by dengue virus. J Med Virol, 2001. 65(2): p. 324-30. 8.King, C.A., R. Anderson, and J.S. Marshall, Dengue virus selectively induces human mast cell chemokine production. J Virol, 2002. 76(16): p. 8408-19. 9.Medin, C.L. and A.L. Rothman, Cell type-specific mechanisms of interleukin-8 induction by dengue virus and differential response to drug treatment. J Infect Dis, 2006. 193(8): p. 1070-7. 10.Lin, Y.L., et al., Involvement of oxidative stress, NF-IL-6, and RANTES expression in dengue-2-virus-infected human liver cells. Virology, 2000. 276(1): p. 114-26. 11.Talavera, D., et al., IL8 release, tight junction and cytoskeleton dynamic reorganization conducive to permeability increase are induced by dengue virus infection of microvascular endothelial monolayers. J Gen Virol, 2004. 85(Pt 7): p. 1801-13. 12.Mukaida, N., Pathophysiological roles of interleukin-8/CXCL8 in pulmonary diseases. Am J Physiol Lung Cell Mol Physiol, 2003. 284(4): p. L566-77. 13.Baggiolini, M., P. Loetscher, and B. Moser, Interleukin-8 and the chemokine family. Int J Immunopharmacol, 1995. 17(2): p. 103-8. 14.Hoffmann, E., et al., Multiple control of interleukin-8 gene expression. J Leukoc Biol, 2002. 72(5): p. 847-55. 15.Nozell, S., et al., Mechanism of IFN-beta-mediated inhibition of IL-8 gene expression in astroglioma cells. J Immunol, 2006. 177(2): p. 822-30. 16.Raghupathy, R., et al., Elevated levels of IL-8 in dengue hemorrhagic fever. J Med Virol, 1998. 56(3): p. 280-5. 17.Bosch, I., et al., Increased production of interleukin-8 in primary human monocytes and in human epithelial and endothelial cell lines after dengue virus challenge. J Virol, 2002. 76(11): p. 5588-97. 18.Huang, Y.H., et al., Dengue virus infects human endothelial cells and induces IL-6 and IL-8 production. Am J Trop Med Hyg, 2000. 63(1-2): p. 71-5. 19.Seneviratne, S.L., G.N. Malavige, and H.J. de Silva, Pathogenesis of liver involvement during dengue viral infections. Trans R Soc Trop Med Hyg, 2006. 100(7): p. 608-14. 20.Suksanpaisan, L., A. Cabrera-Hernandez, and D.R. Smith, Infection of human primary hepatocytes with dengue virus serotype 2. J Med Virol, 2007. 79(3): p. 300-7. 21.Avirutnan, P., et al., Dengue virus infection of human endothelial cells leads to chemokine production, complement activation, and apoptosis. J Immunol, 1998. 161(11): p. 6338-46. 22.Huang, S., et al., Immune response in mice that lack the interferon-gamma receptor. Science, 1993. 259(5102): p. 1742-5. 23.Muller, U., et al., Functional role of type I and type II interferons in antiviral defense. Science, 1994. 264(5167): p. 1918-21. 24.Ho, L.J., et al., Dengue virus type 2 antagonizes IFN-alpha but not IFN-gamma antiviral effect via down-regulating Tyk2-STAT signaling in the human dendritic cell. J Immunol, 2005. 174(12): p. 8163-72. 25.Randall, R.E. and S. Goodbourn, Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures. J Gen Virol, 2008. 89(Pt 1): p. 1-47. 26.Samuel, C.E., Antiviral actions of interferons. Clin Microbiol Rev, 2001. 14(4): p. 778-809, table of contents. 27.Leonard, W.J., Role of Jak kinases and STATs in cytokine signal transduction. Int J Hematol, 2001. 73(3): p. 271-7. 28.Bromberg, J. and J.E. Darnell, Jr., The role of STATs in transcriptional control and their impact on cellular function. Oncogene, 2000. 19(21): p. 2468-73. 29.Kim, H.S. and M.S. Lee, STAT1 as a key modulator of cell death. Cell Signal, 2007. 19(3): p. 454-65. 30.Cooney, R.N., Suppressors of cytokine signaling (SOCS): inhibitors of the JAK/STAT pathway. Shock, 2002. 17(2): p. 83-90. 31.Stephanou, A. and D.S. Latchman, STAT-1: a novel regulator of apoptosis. Int J Exp Pathol, 2003. 84(6): p. 239-44. 32.O'Shea, J.J., M. Gadina, and R.D. Schreiber, Cytokine signaling in 2002: new surprises in the Jak/Stat pathway. Cell, 2002. 109 Suppl: p. S121-31. 33.Imada, K. and W.J. Leonard, The Jak-STAT pathway. Mol Immunol, 2000. 37(1-2): p. 1-11. 34.Takeda, K. and S. Akira, STAT family of transcription factors in cytokine-mediated biological responses. Cytokine Growth Factor Rev, 2000. 11(3): p. 199-207. 35.Qing, Y. and G.R. Stark, Alternative activation of STAT1 and STAT3 in response to interferon-gamma. J Biol Chem, 2004. 279(40): p. 41679-85. 36.Shen, Y., et al., Constitutively activated Stat3 protects fibroblasts from serum withdrawal and UV-induced apoptosis and antagonizes the proapoptotic effects of activated Stat1. Proc Natl Acad Sci U S A, 2001. 98(4): p. 1543-8. 37.Ho, H.H. and L.B. Ivashkiv, Role of STAT3 in type I interferon responses. Negative regulation of STAT1-dependent inflammatory gene activation. J Biol Chem, 2006. 281(20): p. 14111-8. 38.Medin, C.L., K.A. Fitzgerald, and A.L. Rothman, Dengue virus nonstructural protein NS5 induces interleukin-8 transcription and secretion. J Virol, 2005. 79(17): p. 11053-61. 39.Levy, D.E. and J.E. Darnell, Jr., Stats: transcriptional control and biological impact. Nat Rev Mol Cell Biol, 2002. 3(9): p. 651-62. 40.Pang, T., M.J. Cardosa, and M.G. Guzman, Of cascades and perfect storms: the immunopathogenesis of dengue haemorrhagic fever-dengue shock syndrome (DHF/DSS). Immunol Cell Biol, 2007. 85(1): p. 43-5. 41.Gagnon, S.J., et al., Cytokine gene expression and protein production in peripheral blood mononuclear cells of children with acute dengue virus infections. J Med Virol, 2002. 67(1): p. 41-6. 42.Tsai, Y.T., et al., Human TLR3 recognizes dengue virus and modulates viral replication in vitro. Cell Microbiol, 2009. 11(4): p. 604-15. 43.Bozza, F.A., et al., Multiplex cytokine profile from dengue patients: MIP-1beta and IFN-gamma as predictive factors for severity. BMC Infect Dis, 2008. 8: p. 86. 44.Okamoto, S., et al., The interleukin-8 AP-1 and kappa B-like sites are genetic end targets of FK506-sensitive pathway accompanied by calcium mobilization. J Biol Chem, 1994. 269(11): p. 8582-9. 45.Barboric, M., et al., NF-kappaB binds P-TEFb to stimulate transcriptional elongation by RNA polymerase II. Mol Cell, 2001. 8(2): p. 327-37. 46.Luecke, H.F. and K.R. Yamamoto, The glucocorticoid receptor blocks P-TEFb recruitment by NFkappaB to effect promoter-specific transcriptional repression. Genes Dev, 2005. 19(9): p. 1116-27. 47.Bouchard, C., et al., Myc-induced proliferation and transformation require Akt-mediated phosphorylation of FoxO proteins. EMBO J, 2004. 23(14): p. 2830-40. 48.Ryser, S., et al., The rate of c-fos transcription in vivo is continuously regulated at the level of elongation by dynamic stimulus-coupled recruitment of positive transcription elongation factor b. J Biol Chem, 2007. 282(7): p. 5075-84. 49.Cheranov, S.Y., et al., The 15(S)-hydroxyeicosatetraenoic acid-induced angiogenesis requires Janus kinase 2-signal transducer and activator of transcription-5B-dependent expression of interleukin-8. Blood, 2009. 113(23): p. 6023-33. 50. H. Zhao et al., Region 752–761 of STAT3 is critical for SRC-1 recruitment and Ser727 phosphorylation.BBRC. 2004. 325: p. 541-48
|